A smart microcapsule for targeted therapy of IBD is prepared through droplet microfluidics. It can achieve sequential burst–sustained drug release, which is appropriate for the treatment of IBD from the point of view of pharmacology and pathology.
No takes yet. Share an insight, caveat, or question.
Jiang et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: